[go: up one dir, main page]

MX2009004620A - Sistema de administracion para el tratamiento remoto de un animal. - Google Patents

Sistema de administracion para el tratamiento remoto de un animal.

Info

Publication number
MX2009004620A
MX2009004620A MX2009004620A MX2009004620A MX2009004620A MX 2009004620 A MX2009004620 A MX 2009004620A MX 2009004620 A MX2009004620 A MX 2009004620A MX 2009004620 A MX2009004620 A MX 2009004620A MX 2009004620 A MX2009004620 A MX 2009004620A
Authority
MX
Mexico
Prior art keywords
delivery system
animal
remote treatment
remote
treatment
Prior art date
Application number
MX2009004620A
Other languages
English (en)
Inventor
Grant Weyer
Simon Robert Sanford Trickey
Timothy Donald Rose
Original Assignee
Veterinary Encapsulation Biosc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterinary Encapsulation Biosc filed Critical Veterinary Encapsulation Biosc
Publication of MX2009004620A publication Critical patent/MX2009004620A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/40—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information of target-marking, i.e. impact-indicating type
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/46—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances
    • F42B12/54—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances by implantation, e.g. hypodermic projectiles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Combustion & Propulsion (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un sistema de administración remota para tratamiento que comprende un proyectil de dosaje substancialmente no-penetrante de la piel conteniendo un agente biológico activo y un portador transdérmico.
MX2009004620A 2006-11-01 2007-10-31 Sistema de administracion para el tratamiento remoto de un animal. MX2009004620A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85574506P 2006-11-01 2006-11-01
PCT/AU2007/001651 WO2008052263A1 (en) 2006-11-01 2007-10-31 Delivery system for remote treatment of an animal

Publications (1)

Publication Number Publication Date
MX2009004620A true MX2009004620A (es) 2009-05-15

Family

ID=39343692

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004620A MX2009004620A (es) 2006-11-01 2007-10-31 Sistema de administracion para el tratamiento remoto de un animal.

Country Status (6)

Country Link
US (3) US8425932B2 (es)
AR (1) AR063446A1 (es)
AU (1) AU2007314150B2 (es)
BR (1) BRPI0716696B1 (es)
MX (1) MX2009004620A (es)
WO (1) WO2008052263A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2008052263A1 (en) 2006-11-01 2008-05-08 Veterinary Encapsulation Biosciences Pty Ltd Delivery system for remote treatment of an animal
DK2883545T3 (en) * 2007-06-07 2018-11-05 Bayer Animal Health Gmbh Control of ectoparasites
US8404260B2 (en) 2008-04-02 2013-03-26 Bayer Cropscience Lp Synergistic pesticide compositions
FR2933298B1 (fr) * 2008-07-01 2015-05-22 Greenvet Poudre galenique triphasee a usage veterinaire a destination des oiseaux servant a vehiculer des agents actifs tels que: insecticides,insectifuges et tout autres substances
GB2464449B (en) * 2008-09-05 2011-10-12 Norbrook Lab Ltd A topical ectoparasticide composition
CN102599175A (zh) * 2008-12-31 2012-07-25 浙江世佳科技有限公司 藻酸丙二醇酯和阿维菌素的乳油
CN102613215A (zh) * 2008-12-31 2012-08-01 浙江世佳科技有限公司 藻酸丙二醇酯和甲胺基阿维菌素苯甲酸盐的乳油
AU2011301767B2 (en) * 2010-09-13 2014-12-18 Smartvet Pty Ltd System for oral delivery of an agent to an animal
US10024623B2 (en) * 2010-09-19 2018-07-17 Dan Elkins Remote controlled animal dart gun
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9480669B2 (en) 2015-01-06 2016-11-01 The Regents Of The University Of California Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
US9549904B2 (en) 2012-06-06 2017-01-24 Thomas Bryan Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
US11224618B2 (en) 2012-04-16 2022-01-18 Zemtsov Enterprises, Llc Formulations and methods for treatment of acne and inflammatory skin conditions
US9200877B1 (en) * 2012-05-02 2015-12-01 Darren Rubin Biological active bullets, systems, and methods
AU2013204030B2 (en) * 2012-06-22 2016-04-21 Smartvet Pty Ltd Dosage Regime for Animal Treatment
US20140121230A1 (en) * 2012-11-01 2014-05-01 Emmanuel Gonzales De Asis Topical parasiticidal formulation
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2014179831A1 (en) * 2013-05-10 2014-11-13 Smartvet Pty Ltd Dosage projectile for remotely treating an animal
US9470489B2 (en) * 2013-05-14 2016-10-18 Kerry Thaddeus Bowden Airsoft marking round
CN104030992B (zh) * 2014-03-20 2016-03-23 东南大学 一种地昔尼尔药物晶型ⅱ及其制备方法
CL2014000989A1 (es) * 2014-04-17 2014-10-17 Univ Santiago Chile Dispositivo subdermal de liberacion prolongada y lenta para prevencion, tratamiento y monitoreo de parasitos, que comprende al menos una lactona macrociclica tal como ivermectina y/o dormectina, opcionalmente nanoparticulas o microparticulas de zeolita, una matriz polimerica y medios de monitoreo, dentro de un circuito integrado.
US9234729B2 (en) 2014-06-05 2016-01-12 Pneu-Dart, Inc. Injection dart
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
US20170027677A1 (en) * 2015-07-27 2017-02-02 The United States Of America, As Represented By The Secretary Of Agriculture Dart Delivery System
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US10077976B2 (en) 2016-09-28 2018-09-18 BRT Medical LLC Illuminating assembly, projectile and projectile tail
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
WO2018226987A1 (en) 2017-06-07 2018-12-13 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
WO2020172709A1 (en) * 2019-02-27 2020-09-03 Smartvet Pty Ltd Dosage projectile and method of manufacture
US20200282014A1 (en) * 2019-03-05 2020-09-10 Hoffman Technologies Llc Percutaneous anti-microbiota formulations
CN110680803A (zh) * 2019-10-17 2020-01-14 广东省农业科学院动物卫生研究所 一种塞拉菌素醇质体制剂及其制备方法和应用
WO2022170027A1 (en) 2021-02-04 2022-08-11 Edenbridge Pharmaceuticals, LLC Inhaled ivermectin
CN114259464B (zh) * 2021-11-25 2022-11-22 吉林大学 一种复方莫昔克丁外用滴剂
US12109176B1 (en) 2023-04-20 2024-10-08 Thomas Bryan Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3528662A (en) * 1967-08-28 1970-09-15 John M Merchant Material dispensing projectile
JPH07143836A (ja) 1993-11-24 1995-06-06 Makoto Nishimura こませの撒布方法及びこれに使用するこませ並びにガン
AU3142595A (en) 1994-08-01 1996-03-04 Deborah Hellings A non-toxic, edible, and biodegradable skeet and method of making the same
NL9401534A (nl) * 1994-09-21 1996-05-01 Gijsbertus Gerardus Petrus Van Gebruik van zetmeel voor parenterale toepassingen.
US6393992B1 (en) * 1996-11-18 2002-05-28 Jaycor Tactical Systems, Inc. Non-lethal projectile for delivering an inhibiting substance to a living target
GB0018593D0 (en) * 2000-07-28 2000-09-13 Brydges Price Richard I Projectile for delivery of a tranquilliser
AU2002248364A1 (en) 2001-01-19 2002-08-12 International Fly Masters, Inc. Chemical agent delivery device and method of using same
AU773534B2 (en) * 2001-08-15 2004-05-27 Nch Corporation Control agent delivery system and method of use
WO2005074672A2 (en) * 2004-02-09 2005-08-18 Simon Robert Sandford Trickey Administration of externally administered treatment substances to animals
WO2008052263A1 (en) 2006-11-01 2008-05-08 Veterinary Encapsulation Biosciences Pty Ltd Delivery system for remote treatment of an animal

Also Published As

Publication number Publication date
AU2007314150A1 (en) 2008-05-08
BRPI0716696A2 (pt) 2014-03-04
US9238001B2 (en) 2016-01-19
AU2007314150B2 (en) 2009-06-04
US20130216483A1 (en) 2013-08-22
US20140341815A1 (en) 2014-11-20
US20100203122A1 (en) 2010-08-12
WO2008052263A1 (en) 2008-05-08
AR063446A1 (es) 2009-01-28
US8802135B2 (en) 2014-08-12
BRPI0716696B1 (pt) 2020-01-21
US8425932B2 (en) 2013-04-23

Similar Documents

Publication Publication Date Title
MX2009004620A (es) Sistema de administracion para el tratamiento remoto de un animal.
WO2010025378A3 (en) Drug delivery implants
GB0906225D0 (en) Magnectic carrier and medical prepartion for controllable delivery and release of active substances, a method of production and method of treatment using ther
WO2006033779A3 (en) Energetically controlled delivery of biologically active material from an implanted medical device
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
MX2009010000A (es) Dispositivo para el suministro de farmaco.
WO2009029958A3 (en) Implantable delivery device
EA201170297A1 (ru) Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
WO2010056922A3 (en) Systems and methods for delivery of biologically active agents
EP2392364A3 (en) Rapamycin coated expandable devices
EP2392363A3 (en) Drug coated expandable devices
MX2009009999A (es) Metodo y dispositivo para suministro de farmacos.
IL189750A (en) Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
WO2008052189A3 (en) Micropore delivery of active substances
MX339125B (es) Endoprotesis de metal desnudo con receptaculos eluyentes de farmacos.
GB2483505B (en) Devices for transdermal drug delivery
WO2011039736A3 (en) Device and method for drug delivery to a targeted skin layer
ZA200902579B (en) Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
MX365688B (es) Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino.
MX367070B (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata.
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
IN2013MN00758A (es)
EP4400165A3 (en) Vaginal drug delivery device
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration
HC Change of company name or juridical status